MSH|^~\&|MIC|BH|||202002131101||ORU^R01|4167422|D|2.3|||AL|NE
PID|1||BH00004008|BH4008|FHLATIF^PLIS^||19751128|M||||||||||BH000020/17|9698716815
OBR|1|39321^MIC|00029670^20:U0000017R^MIC^20:U17^39321|500.1000^U^Urine Culture^^^630-4||202002131035|202002131034|||||||202002131034|Urine^^^Condom|||||||||MB|C||||
OBX|1|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUMIX|1|||||||F|||202002131101
OBX|2|ST|500.1000^U^Urine Culture^^^630-4^R:100-1000|1|10-100|x 10*6 CFU/L|||||F|||202002131101
OBX|3|ST|500.1000^U^Urine Culture^^^630-4^P:MIXU|1|||||||F|||202002131101
OBX|4|ST|500.1000^U^Urine Culture^^^630-4^R:CONT|1|Contaminants||||||F|||202002131101
OBX|5|CE|500.1000^U^Urine Culture^^^630-4^O:SAUR|1.1|SAUR^Staphylococcus aureus||||||F|||202002131101
OBX|6|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.1|||||||F|||202002131101
OBX|7|ST|500.1000^U^Urine Culture^^^630-4^R:1000|1.1|>100|x 10*6 CFU/L||A|||F|||202002131101
OBX|8|CE|500.1000^U^Urine Culture^^^630-4^O:SGA|1.2|SGA^Group A streptococcus||||||F|||202002131101
OBX|9|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.2|||||||F|||202002131101
OBX|10|ST|500.1000^U^Urine Culture^^^630-4^R:1000|1.2|>100|x 10*6 CFU/L||A|||F|||202002131101
OBX|11|CE|500.1000^U^Urine Culture^^^630-4^O:ECOL|1.3|ECOL^Escherichia coli|||A|||F|||202002131101
OBX|12|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.3|||||||F|||202002131101
OBX|13|ST|500.1000^U^Urine Culture^^^630-4^R:100-1000|1.3|10-100|x 10*6 CFU/L||A|||F|||202002131101
OBX|14|ST|500.1000^U^Urine Culture^^^630-4|1.3|||||||F|||202002131101
NTE|1||Beta hemolytic group A Streptococci are universally
NTE|2||susceptible to the penicillins and cephalosporins, and
NTE|3||resistant to ciprofloxacin and
NTE|4||trimethoprim/sulfamethoxazole.  Alternate antibiotics are
NTE|5||clindamycin (80% susceptible) and erythromycin (75%
NTE|6||susceptible).
NTE|7||************************************************************
NTE|8||         ******** This is a Corrected Result ********
NTE|9||************************************************************
NTE|10||A prior result that was reported as final has been changed.
NTE|11||Prior Result: MRSA
NTE|12||Corrected Result: Staph aureus
OBR|2||00029670^20:U0000017R^MIC^20:U17^39321|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||202002131035|202002131034|||||||202002131034|Urine^^^Condom|||||||||MB|C|U^1.1|||39321^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||202002131101
OBX|2|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||202002131101
OBX|3|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||S|||F|||202002131101
OBX|4|ST|500.700^FD^Nitrofurantoin^^363-2^363-2|||||S|||F|||202002131101
OBX|5|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||202002131101
OBX|6|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||F|||202002131101
OBX|7|ST|700.100^DOX^Doxycycline^^225-3^225-3|||||S|||F|||202002131101
OBX|8|ST|800.000^VA^Vancomycin^^524-9^524-9|||||S|||F|||202002131101
OBR|3||00029670^20:U0000017R^MIC^20:U17^39321|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||202002131035|202002131034|||||||202002131034|Urine^^^Condom|||||||||MB|C|U^1.3|||39321^MIC
OBX|1|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||202002131101
OBX|2|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||202002131101
OBX|3|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||202002131101
OBX|4|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||202002131101
OBX|5|ST|300.200^GM^Gentamicin^^267-5^267-5|||||S|||F|||202002131101
OBX|6|ST|400.350^FOS^Fosfomycin^^25653-7^25653-7|||||S|||F|||202002131101
OBX|7|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||S|||F|||202002131101
OBX|8|ST|500.700^FD^Nitrofurantoin^^363-2^363-2|||||S|||F|||202002131101
OBX|9|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||202002131101
OBX|10|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||F|||202002131101

MSH|^~\&|MIC|LMH|||202002131101||ORU^R01|4167423|D|2.3|||AL|NE
PID|1||LM00005528|LM5330|LUMEDTEST^TORONTO^||19880908|F||||||||||LM000762/19|9874745485
OBR|1|39322^MIC|00029671^20:U0000018R^MIC^20:U18^39322|500.1000^U^Urine Culture^^^630-4||202002131035|202002131033|||||||202002131033|Urine^^^Foley catheter|||||||||MB|C||||
OBX|1|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUMIX|1|||||||F|||202002131101
OBX|2|ST|500.1000^U^Urine Culture^^^630-4^R:100-1000|1|10-100|x 10*6 CFU/L|||||F|||202002131101
OBX|3|ST|500.1000^U^Urine Culture^^^630-4^P:MIXU|1|||||||F|||202002131101
OBX|4|ST|500.1000^U^Urine Culture^^^630-4^R:CONT|1|Contaminants||||||F|||202002131101
OBX|5|CE|500.1000^U^Urine Culture^^^630-4^O:SAUR|1.1|SAUR^Staphylococcus aureus||||||F|||202002131101
OBX|6|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.1|||||||F|||202002131101
OBX|7|ST|500.1000^U^Urine Culture^^^630-4^R:1000|1.1|>100|x 10*6 CFU/L||A|||F|||202002131101
OBX|8|CE|500.1000^U^Urine Culture^^^630-4^O:SGA|1.2|SGA^Group A streptococcus||||||F|||202002131101
OBX|9|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.2|||||||F|||202002131101
OBX|10|ST|500.1000^U^Urine Culture^^^630-4^R:1000|1.2|>100|x 10*6 CFU/L||A|||F|||202002131101
OBX|11|CE|500.1000^U^Urine Culture^^^630-4^O:ECOL|1.3|ECOL^Escherichia coli|||A|||F|||202002131101
OBX|12|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.3|||||||F|||202002131101
OBX|13|ST|500.1000^U^Urine Culture^^^630-4^R:100-1000|1.3|10-100|x 10*6 CFU/L||A|||F|||202002131101
OBX|14|ST|500.1000^U^Urine Culture^^^630-4|1.3|||||||F|||202002131101
NTE|1||Beta hemolytic group A Streptococci are universally
NTE|2||susceptible to the penicillins and cephalosporins, and
NTE|3||resistant to ciprofloxacin and
NTE|4||trimethoprim/sulfamethoxazole.  Alternate antibiotics are
NTE|5||clindamycin (80% susceptible) and erythromycin (75%
NTE|6||susceptible).
NTE|7||************************************************************
NTE|8||         ******** This is a Corrected Result ********
NTE|9||************************************************************
NTE|10||A prior result that was reported as final has been changed.
NTE|11||Prior Result: MRSA
NTE|12||Corrected Result: Staph aureus
OBR|2||00029671^20:U0000018R^MIC^20:U18^39322|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||202002131035|202002131033|||||||202002131033|Urine^^^Foley catheter|||||||||MB|C|U^1.1|||39322^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||202002131101
OBX|2|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||202002131101
OBX|3|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||S|||F|||202002131101
OBX|4|ST|500.700^FD^Nitrofurantoin^^363-2^363-2|||||S|||F|||202002131101
OBX|5|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||202002131101
OBX|6|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||F|||202002131101
OBX|7|ST|700.100^DOX^Doxycycline^^225-3^225-3|||||S|||F|||202002131101
OBX|8|ST|800.000^VA^Vancomycin^^524-9^524-9|||||S|||F|||202002131101
OBR|3||00029671^20:U0000018R^MIC^20:U18^39322|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||202002131035|202002131033|||||||202002131033|Urine^^^Foley catheter|||||||||MB|C|U^1.3|||39322^MIC
OBX|1|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||202002131101
OBX|2|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||202002131101
OBX|3|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||202002131101
OBX|4|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||202002131101
OBX|5|ST|300.200^GM^Gentamicin^^267-5^267-5|||||S|||F|||202002131101
OBX|6|ST|400.350^FOS^Fosfomycin^^25653-7^25653-7|||||S|||F|||202002131101
OBX|7|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||S|||F|||202002131101
OBX|8|ST|500.700^FD^Nitrofurantoin^^363-2^363-2|||||S|||F|||202002131101
OBX|9|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||202002131101
OBX|10|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||F|||202002131101